Research presented at the American Society of Hematology (ASH) annual meeting in Orlando indicates that stem cell transplants using mismatched unrelated donors (MMUDs) with less than...
Treatment with a novel antibody therapy has shown the potential to eliminate residual traces of multiple myeloma, a type of blood cancer, according to interim results...
